SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-054654
Filing Date
2022-05-02
Accepted
2022-05-02 16:06:53
Documents
6
Period of Report
2022-05-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2213541-1_def14a.htm DEF 14A 1658018
2 GRAPHIC lg_intercept-new.jpg GRAPHIC 13597
3 GRAPHIC sg_jeromedurso-bw.jpg GRAPHIC 11366
4 GRAPHIC tm2213541d1-lc_netsalesbw.jpg GRAPHIC 99010
5 GRAPHIC tm2213541d1-pxy_proxy1bw.jpg GRAPHIC 793542
6 GRAPHIC tm2213541d1-pxy_proxy2bw.jpg GRAPHIC 817424
  Complete submission text file 0001104659-22-054654.txt   4042405
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35668 | Film No.: 22881935
SIC: 2834 Pharmaceutical Preparations